Blood Urea Nitrogen Diagnostics Market Segmentation:
Sample Type Segment Analysis
Blood serum holds the highest market share of 66% in the sample type segment in the blood urea nitrogen diagnostics market within the forecast period due to its accuracy and reliability in detecting kidney function abnormalities. Serum samples produce consistent results in measuring blood urea nitrogen levels; this was instrumental for diagnosing and monitoring renal diseases. According to the CDC May 2024 report, the rate of chronic kidney diseases is 11.8% in men and 14.4% in women in the U.S., thus bringing blood serum testing as one of the important tools for early diagnosis and management of chronic kidney diseases. Even though blood tests are preferred at the serum level during processing, the speed remains higher with minimal interference offered during sample collection from other sample types.
Product Type Segment Analysis
The diagnostics sub-segment dominates the product type segment in the blood urea nitrogen market since it generates demand for early detection and monitoring of renal disorders. The rise in the number of cases of chronic kidney disease (CKD) and acute kidney injury (AKI) has forced healthcare providers to depend on effective diagnostic procedures. As per the CDC May 2024 report, CKD is found to be common in people aged 65 years or older (34%) as compared to people aged 45 to 64 years (12%) and people aged 18 to 44 (6%), thereby accentuating further the need for diagnostic methods such as BUN testing for the minimization of the disease progression. The advances in diagnostic technologies have supplemented this segment's growth.
Application Segment Analysis
Kidney function testing in the application is the leading application driving the blood urea nitrogen diagnostics market. Blood urea nitrogen, or BUN level, determines the ability of the kidneys to filter out waste and is important for the early detection of kidney impairment or failure. According to the CDC’s May 2024 report, CKD is estimated to have been in more than 1 in 7 adults in the U.S.- approximately 35.5 million people or 14%, accentuating the increasing need for kidney function tests. Such early and periodic tests help keep the kidneys healthy and halt the progression of renal cases to end-stage, thus making this application paramount in the market.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Sub-segments |
|
Product Type |
|
|
End user |
|
|
Application |
|
|
Technology |
|
|
Sample Type |
|
|
Distribution Channel |
|
